Showing 1901-1910 of 2235 results for "".
- Hydrafacial and Glytone Team Up to Launch New Boosterhttps://modernaesthetics.com/news/hydrafacial-and-glytone-team-up-to-launch-new-booster-1/2473323/The Beauty Health Company’s Hydrafacial is rolling out a new exfoliating booster co-created with Glytone. The Glytone AHA Resurfacing Cellular Booster leverages a unique combination of three alpha hydroxy acids (AHAs) that may help improve the appearance of skin surface and textur
- Allergan Aesthetics Celebrates Fourth Annual BOTOX Cosmetic Dayhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-fourth-annual-botox-cosmetic-day/2473322/Allergan Aesthetics is inviting people across the country to take a "Moment for You" on Wednesday, Nov. 16, 2022 to celebrate the biggest event of the year for Botox Cosmetic. For this year's celebration, BOTOX Cosmetic is sharing two exclusive offers availa
- Evio Beauty Supports Domestic Violence Survivorshttps://modernaesthetics.com/news/evio-beauty-supports-domestic-violence-survivors/2473319/Evio Beauty is teaming up with FreeFrom, a US-based non-profit organization dedicated to helping survivors of intimate partner violence achieve economic justice and long-term financial stability. Evio will donate one dollar from every sale of their Lip Serum (in any shade) to FreeFrom.
- U.S. FDA Clears EndyMed’s Pure Laser Hair Removal Devicehttps://modernaesthetics.com/news/us-fda-clears-endymeds-pure-laser-hair-removal-device/2473318/The US Food and Drug Administration has cleared Endymed Ltd’s Pure Laser hair removal device for the marketing and sales. The Pure Laser was developed in the Company's labs by its subsidiary Endymed Medical Ltd. The Company intends to commence marketing in the US th
- FDA Clears Aesthetics Biomedical's Vivace Ultrahttps://modernaesthetics.com/news/fda-clears-aesthetics-biomedicals-vivace-ultra/2473317/The FDA has cleared Aesthetics Biomedical Inc.’s Vivace Ultra, the next generation and of personalized aesthetics, for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. An innovative reimagination and technical upgrade of the legacy Vivace
- New from Alastin: Meet A-LUMINATE BRIGHTENING SERUMhttps://modernaesthetics.com/news/new-from-alastin-meet-a-luminate-brightening-serum/2473316/Galderma’s ALASTIN Skincare is rolling out A-LUMINATE BRIGHTENING SERUM to help reduce the appearance of surface pigmentation without any harsh, irritating ingredients. A-LUMINATE BRIGHTENING SERUM contains a multifaceted blend of peptides, antioxidants, and targeted in
- Right to Repair: How Developments Could Affect Aesthetics Practiceshttps://modernaesthetics.com/news/right-to-repair-how-developments-could-affect-aesthetics-practices/2473311/Recent action on the federal level has renewed interest in “Right to Repair” legislation, and the medical aesthetics industry is eyeing developments that might directly impact aesthetic practices and medspas. Right to Repair legislation dates back to the 1970s, and mos
- Galderma Gives Back: Brand Partners with NBCF to Launch Campaign Elevating Skin Stories of Breast Cancer Survivorshttps://modernaesthetics.com/news/galderma-gives-back-brand-partners-with-nbcf-to-launch-campaign-elevating-skin-stories-of-breast-cancer-survivors/2473307/Galderma is continuing its partnership with National Breast Cancer Foundation Inc. (NBCF) with a new campaign that elevates the skin stories of breast cancer survivors. Galderma is featuring the personal stories and treatment journeys of breast cancer survivors who receivedRestylan
- New Research Highlights the Efficacy and Safety Profile of Revance's DAXXIFYhttps://modernaesthetics.com/news/new-research-highlights-the-efficacy-and-safety-profile-of-revances-daxxify/2473304/Two new studies highlight the efficacy and safety profile of Revance Therapeutics, Inc.’s newly approved DAXXIFY (DaxibotulinumtoxinA-lanm). Glabellar injection of DAXXIFY showed a positive effect on eyebrow position, with a modest reduction in forehead muscle activity in&nbs
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra